This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Gladman, D D Articles by Urowitz, M. B Search for Related Content PubMed PubMed Citation Articles by Gladman, D D Articles by Urowitz, M. B Pubmed/NCBI databases Medline Plus Health Information Lupus Social Bookmarking                   What's this?

The SLICC/ACR damage index: progress report and experience in the field

University of Toronto, Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada; Centre for Prognosis Studies in The Rheumatic Diseases, University Health Network, Toronto Western Hospital, 399 Bathurst Street 1-318, Toronto, Ontario, M52 2S8, Canada; Tel: (+1) 416 603 5753; Fax: (+1) 416 603 9387

Murray B Urowitz

University of Toronto, Toronto, Ontario, Canada

The SLICC/ACR damage index for SLE was developed to assess accumulated damage since the onset of the disease. The damage includes non-reversible changes in organs and systems affected by the disease process itself, its therapy, or inter-current illness. This paper describes the development of the damage index, its validation and its use. It is recommended as an outcome measure for longitudinal studies of prognosis and response to new therapies, and as a stratification measure for clinical trials.

Key Words: SLICC/ACR • damage index • prognosis • outcome • SLE

Lupus, Vol. 8, No. 8, 632-637 (1999)
DOI: 10.1191/096120399680411335


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. J. Barry, N. Sutcliffe, D. A. Isenberg, E. Price, F. Goldblatt, M. Adler, A. Canavan, J. Hamburger, A. Richards, M. Regan, et al. The Sjogren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjogren's syndrome Rheumatology, August 1, 2008; 47(8): 1193 - 1198. [Abstract] [Full Text] [PDF]

				L.T. Hiraki, J. Hamilton, and E.D. Silverman Review: Measuring permanent damage in pediatric systemic lupus erythematosus Lupus, August 1, 2007; 16(8): 657 - 662. [Abstract] [PDF]

				H I Brunner, A Bishnoi, A C Barron, L J Houk, A Ware, Y Farhey, A B Mongey, C F Strife, T B Graham, and M H Passo Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus Lupus, April 1, 2006; 15(4): 198 - 206. [Abstract] [PDF]

				M Aringer, T A Stamm, D S Pisetsky, C H Yarboro, A Cieza, J S Smolen, and G Stucki ICF Core Sets: how to specify impairment and function in systemic lupus erythematosus Lupus, April 1, 2006; 15(4): 248 - 253. [Abstract] [PDF]

				G H Stummvoll, M Aringer, J S Smolen, S Schmaldienst, E Jimenez-Boj, W H Horl, W B Graninger, and K Derfler IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study Ann Rheum Dis, July 1, 2005; 64(7): 1015 - 1021. [Abstract] [Full Text] [PDF]

				A. Doria, S. Rinaldi, M. Ermani, F. Salaffi, L. Iaccarino, A. Ghirardello, S. Zampieri, S. Della Libera, G. Perini, and S. Todesco Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants Rheumatology, December 1, 2004; 43(12): 1580 - 1586. [Abstract] [Full Text] [PDF]

				A Zink, R Fischer-Betz, K Thiele, J Listing, D Huscher, E Gromnica-Ihle, C Specker, M Schneider, and German Collaborative Arthritis Centres Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the national database of the German Collaborative Arthritis Centres Lupus, July 1, 2004; 13(7): 529 - 536. [Abstract] [PDF]

				L N. Moorthy, L Robbins, M J Harrison, M G. Peterson, N Cox, K B Onel, and T J. Lehman Quality of life in paediatric lupus Lupus, April 1, 2004; 13(4): 234 - 240. [Abstract] [PDF]

				M. Soares, L Reis, J A. Papi, and C R. Cardoso Rate, pattern and factors related to damage in Brazilian systemic lupus erythematosus patients Lupus, October 1, 2003; 12(10): 788 - 794. [Abstract] [PDF]

				Y Ioannou and D A Isenberg Current concepts for the management of systemic lupus erythematosus in adults: a therapeutic challenge Postgrad. Med. J., October 1, 2002; 78(924): 599 - 606. [Abstract] [Full Text] [PDF]

				A. S. Wilson, G. D. Kitas, D. M. Carruthers, C. Reay, J. Skan, S. Harris, G. J. Treharne, S. P. Young, and P. A. Bacon Computerized information-gathering in specialist rheumatology clinics: an initial evaluation of an electronic version of the Short Form 36 Rheumatology, March 1, 2002; 41(3): 268 - 273. [Abstract] [Full Text] [PDF]

				P Rahman, D D Gladman, M B Urowitz, D Hallett, and L S Tam Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus Lupus, February 1, 2001; 10(2): 93 - 96. [Abstract] [PDF]

				M B Urowitz and D D Gladman Accelerated atheroma in lupus--background Lupus, March 1, 2000; 9(3): 161 - 165. [Abstract] [PDF]

				M. B. Urowitz and D. D. Gladman How to improve morbidity and mortality in systemic lupus erythematosus Rheumatology, March 1, 2000; 39(3): 238 - 244. [Full Text] [PDF]